Subcellular localization of Nox4 and regulation in diabetes

Karen Block1, Yves Gorin, Hanna E Abboud

  • 1Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229, USA.

Insights

Mitochondria harbor a previously unknown source of reactive oxygen species (ROS). The study identifies Nox4, a key enzyme in ROS production, within mitochondria, suggesting new therapeutic targets for diseases linked to oxidative stress.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pathophysiology

Background:

  • Oxidative stress contributes to human diseases, with mitochondria playing a role in oxidative pathways.
  • NAD(P)H oxidases are present in various cell types, with Nox4 being a significant source of reactive oxygen species (ROS).

Purpose of the Study:

  • To investigate the localization and function of Nox4 within mitochondria.
  • To determine if mitochondria represent a novel source of ROS.

Main Methods:

  • Generated specific Nox4 antibodies for immunoblot and immunofluorescence confocal microscopy.
  • Utilized siRNA-mediated knockdown to assess Nox4 function in purified mitochondria.
  • Employed MitoProt, a mitochondrial localization prediction program.

Main Results:

  • Nox4 was confirmed to be present in crude, enriched, and purified mitochondria.
  • Immunofluorescence showed Nox4 co-localization with the mitochondrial marker Mitotracker.
  • Knockdown of Nox4 in purified mitochondria reduced NADPH oxidase activity and blocked glucose-induced superoxide generation.
  • Mitochondrial Nox4 expression was elevated in the kidney cortex of diabetic rats.

Conclusions:

  • A functional Nox4 enzyme is present and regulated within mitochondria.
  • Mitochondria represent a previously undescribed source of ROS.
  • Findings suggest novel therapeutic strategies for diseases involving mitochondrial oxidative stress.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...